CORCEPT THERAPEUTICS INC Earnings Per Share, Basic and Diluted
CORCEPT THERAPEUTICS INC (CORT) reported Earnings Per Share, Basic and Diluted of $0.04 per share for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2018-02-28
- CORCEPT THERAPEUTICS INC earnings per share, basic and diluted for the quarter ending 2017-03-31 was $0.04.
- CORCEPT THERAPEUTICS INC earnings per share, basic and diluted for the quarter ending 2016-12-31 was $0.04, a 300.00% increase year-over-year.
- CORCEPT THERAPEUTICS INC earnings per share, basic and diluted for the quarter ending 2016-09-30 was $0.02.
- CORCEPT THERAPEUTICS INC earnings per share, basic and diluted for the quarter ending 2016-06-30 was $0.01.
- CORCEPT THERAPEUTICS INC earnings per share, basic and diluted for fiscal 2016 was $0.07.
- CORCEPT THERAPEUTICS INC earnings per share, basic and diluted for fiscal 2015 was -$0.06.
- CORCEPT THERAPEUTICS INC earnings per share, basic and diluted for fiscal 2014 was -$0.31.
- CORCEPT THERAPEUTICS INC earnings per share, basic and diluted for fiscal 2013 was -$0.46.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2017-03-31 | $0.04 10-Q · filed 2017-05-02 | |||
| 2016-12-31 | $0.04 10-K · filed 2018-02-28 | $0.07 10-K · filed 2017-03-06 | ||
| 2016-09-30 | $0.02 10-K · filed 2018-02-28 | $0.03 10-Q · filed 2016-11-02 | ||
| 2016-06-30 | $0.01 10-K · filed 2018-02-28 | $0.01 10-Q · filed 2016-08-03 | ||
| 2016-03-31 | $0.00 10-K · filed 2018-02-28 | |||
| 2015-12-31 | $0.01 10-K · filed 2017-03-06 | -$0.06 10-K · filed 2017-03-06 | ||
| 2015-09-30 | -$0.01 10-K · filed 2017-03-06 | -$0.07 10-Q · filed 2016-11-02 | ||
| 2015-06-30 | -$0.02 10-K · filed 2017-03-06 | -$0.06 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | -$0.05 10-K · filed 2017-03-06 | |||
| 2014-12-31 | -$0.04 10-K · filed 2016-03-10 | -$0.31 10-K · filed 2017-03-06 | ||
| 2014-09-30 | -$0.06 10-K · filed 2016-03-10 | -$0.27 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | -$0.07 10-K · filed 2016-03-10 | -$0.21 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | -$0.14 10-K · filed 2016-03-10 | |||
| 2013-12-31 | -$0.11 10-K · filed 2015-03-13 | -$0.46 10-K · filed 2016-03-10 | ||
| 2013-09-30 | -$0.11 10-K · filed 2015-03-13 | -$0.35 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | -$0.12 10-K · filed 2015-03-13 | -$0.24 10-Q · filed 2014-08-08 | ||
| 2013-03-31 | -$0.12 10-K · filed 2015-03-13 | |||
| 2012-12-31 | -$0.11 10-K · filed 2014-03-14 | -$0.41 10-K · filed 2015-03-13 | ||
| 2012-09-30 | -$0.08 10-K · filed 2014-03-14 | -$0.30 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | -$0.09 10-K · filed 2014-03-14 | -$0.22 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | -$0.13 10-K · filed 2014-03-14 | |||
| 2011-12-31 | -$0.12 10-K · filed 2013-03-15 | -$0.39 10-K · filed 2014-03-14 | ||
| 2011-09-30 | -$0.08 10-K · filed 2013-03-15 | -$0.27 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | -$0.11 10-K · filed 2013-03-15 | -$0.19 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | -$0.09 10-K · filed 2013-03-15 | |||
| 2010-12-31 | -$0.38 10-K · filed 2013-03-15 | |||
| 2010-09-30 | -$0.10 10-Q · filed 2011-11-08 | -$0.28 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | -$0.09 10-Q · filed 2011-08-09 | -$0.18 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | -$0.38 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |